Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine for the Treatment for Opioid Use Disorder and Suicidal Ideation in the Emergency Department

NCT06111339 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT06111339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06111339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine for the Treatment for Opioid Use Disorder and Suicidal Ideation in the Emergency Department
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Terminated
Start date
June 14, 2024
Completion date
March 31, 2025
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder, suicidal ideation